HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Mitchell-Riley Syndrome

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Diarrhea
2.	Intestinal Atresia
3.	Cholestasis
4.	Biliary Atresia
5.	Familial duodenal atresia

Experts

1.	Beltrand, Jacques: 1 article (01/2022)
2.	Berteloot, Laureline: 1 article (01/2022)
3.	Besancon, Alix: 1 article (01/2022)
4.	Bismuth, Elise: 1 article (01/2022)
5.	Capri, Yline: 1 article (01/2022)
6.	Carel, Jean Claude: 1 article (01/2022)
7.	Cavé, Hélène: 1 article (01/2022)
8.	Chandra, Vikash: 1 article (01/2022)
9.	Chardot, Christophe: 1 article (01/2022)
10.	Dugelay, Emmanuelle: 1 article (01/2022)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Mitchell-Riley Syndrome:

1.	Transcription Factors (Transcription Factor)IBA 11/01/2019 - "In this context, we studied the role of the transcription factor Rfx6 which had been identified as the cause of Mitchell-Riley syndrome, characterized by neonatal diabetes and congenital malabsorptive diarrhea. " 01/01/2022 - "Caused by biallelic mutations of the gene encoding the transcription factor RFX6, the rare Mitchell-Riley syndrome (MRS) comprises neonatal diabetes, pancreatic hypoplasia, gallbladder agenesis or hypoplasia, duodenal atresia, and severe chronic diarrhea. " 10/29/2021 - "Homozygous mutations in the transcription factor RFX6 are the cause of the Mitchell-Riley syndrome (MRS) associating neonatal diabetes, congenital digestive system, such as biliary atresia, pancreatic hypoplasia, duodenal and/or jejunal atresia, intestinal malrotation, gallbladder aplasia, cholestasis. " 12/01/2015 - "Biallelic truncating or mis-sense mutations in the DNA-binding domain of the RFX6 transcription factor cause an autosomal recessive, syndromic form of neonatal diabetes previously described as Mitchell-Riley syndrome. "
2.	Glucagon-Like Peptide 1 (GLP 1)IBA 01/01/2021 - "Congenital GLP-1 deficiency was identified in patients with Mitchell-Riley syndrome. " 01/01/2021 - "To assess whether glucagon-like peptide-1 (GLP-1) was involved in the pathogenesis of Mitchell-Riley syndrome protracted diarrhea. " 01/01/2021 - "Congenital Glucagon-like Peptide-1 Deficiency in the Pathogenesis of Protracted Diarrhea in Mitchell-Riley Syndrome." 01/01/2021 - "The main outcome was to evaluate whether GLP-1 analogue therapy could improve Mitchell-Riley syndrome protracted diarrhea. "
3.	DNA (Deoxyribonucleic Acid)IBA 12/01/2015 - "Biallelic truncating or mis-sense mutations in the DNA-binding domain of the RFX6 transcription factor cause an autosomal recessive, syndromic form of neonatal diabetes previously described as Mitchell-Riley syndrome. "

Therapies and Procedures

1.	Therapeutics 01/01/2021 - "The main outcome was to evaluate whether GLP-1 analogue therapy could improve Mitchell-Riley syndrome protracted diarrhea. "